Cantor Fitzgerald Initiates Coverage On Trulieve Cannabis with Overweight Rating, Announces Price Target of $15
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiationPrice Target
Cantor Fitzgerald analyst Gabie Ingoglia initiates coverage on Trulieve Cannabis (NYSE:TRLV) with a Overweight rating and announces Price Target of $15.
Cantor Fitzgerald analyst Gabie Ingoglia initiates coverage on Trulieve Cannabis (NYSE:TRLV) with a Overweight rating and announces Price Target of $15.